Payam Nahid

13.4k total citations · 2 hit papers
102 papers, 4.6k citations indexed

About

Payam Nahid is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Payam Nahid has authored 102 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Infectious Diseases, 60 papers in Epidemiology and 35 papers in Surgery. Recurrent topics in Payam Nahid's work include Tuberculosis Research and Epidemiology (87 papers), Mycobacterium research and diagnosis (38 papers) and Infectious Diseases and Tuberculosis (26 papers). Payam Nahid is often cited by papers focused on Tuberculosis Research and Epidemiology (87 papers), Mycobacterium research and diagnosis (38 papers) and Infectious Diseases and Tuberculosis (26 papers). Payam Nahid collaborates with scholars based in United States, Uganda and United Kingdom. Payam Nahid's co-authors include Alimuddin Zumla, Stewart T. Cole, Philip C. Hopewell, Robert M. Jasmer, Leah G. Jarlsberg, Dennis Osmond, L. Masae Kawamura, John L. Johnson, Karen R Steingart and Charles L. Daley and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Payam Nahid

94 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in the development of new tuberculosis drugs and treatment regimens

2013 690 citations Payam Nahid et al. profile →
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies

2018 276 citations Narges Alipanah, Leah G. Jarlsberg et al. PLoS Medicine profile →

Peers

Countries citing papers authored by Payam Nahid

Since Specialization

Citations

This map shows the geographic impact of Payam Nahid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Payam Nahid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Payam Nahid more than expected).

Fields of papers citing papers by Payam Nahid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Payam Nahid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Payam Nahid. The network helps show where Payam Nahid may publish in the future.

Co-authorship network of co-authors of Payam Nahid

This figure shows the co-authorship network connecting the top 25 collaborators of Payam Nahid. A scholar is included among the top collaborators of Payam Nahid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Payam Nahid. Payam Nahid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Tolerability of a Short Course of Linezolid for the Treatment of Predominantly Moderate to Severe Tuberculous Meningitis in Adults With Human Immunodeficiency Virus 2025 ·The Journal of Infectious Diseases ·Felicia C. Chow, (unknown), (unknown), (unknown), (unknown), Edward J. Farrell, Margaret D. Wilson, Payam Nahid, Radojka M. Savić, Fiona V Cresswell, Freddie Kibengo	2
2	Preferences for tuberculosis diagnostic test features among people tested for tuberculosis: a multicountry discrete choice experiment 2025 ·(unknown), Talemwa Nalugwa, (unknown), (unknown), (unknown), Deepa Shankar, (unknown), (unknown), Alfred Andama, Devasahayam Jesudas Christopher, (unknown), Grant Theron, William Worodria, María del Mar Castro, Payam Nahid, Claudia M. Denkinger, Adithya Cattamanchi, Charles Yu, Andrew D. Kerkhoff	0
3	Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein 2024 ·Clinical Infectious Diseases ·Rebecca Crowder, (unknown), Alfred Andama, Devasahayam Jesudas Christopher, (unknown), (unknown), Sandra V. Kik, (unknown), Nguyen Viet Nhung, Patrick Phillips, Morten Rühwald, Grant Theron, William Worodria, Charles Yu, Payam Nahid, Adithya Cattamanchi, Ankur Gupta‐Wright, Claudia M. Denkinger, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
4	Innovative COVID-19 Point-of-Care Diagnostics Suitable for Tuberculosis Diagnosis: A Scoping Review 2024 ·Journal of Clinical Medicine ·(unknown), Sonal Jain, (unknown), Tobias Broger, Chris Isaacs, Grant Theron, Payam Nahid, Adithya Cattamanchi, Claudia M. Denkinger, (unknown)	0
5	Accuracy of Tongue Swab Testing Using Xpert MTB-RIF Ultra for Tuberculosis Diagnosis 2022 ·Journal of Clinical Microbiology ·Alfred Andama, Grant R. Whitman, Rebecca Crowder, (unknown), Devan Jaganath, (unknown), (unknown), Fred C. Semitala, William Worodria, Catherine Cook, Rachel C. Wood, Kris M. Weigel, Alaina M. Olson, (unknown), Midori Kato‐Maeda, Claudia M. Denkinger, Payam Nahid, Gerard A. Cangelosi, Adithya Cattamanchi	38
6	Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments 2022 ·Antimicrobial Agents and Chemotherapy ·(unknown), Allison Bauman, (unknown), Karen Rossmassler, (unknown), (unknown), Martin I. Voskuil, Maria Garcia‐Cremades, Rada Savic, Payam Nahid, Camille M. Moore, Rokeya Tasneen, Eric L. Nuermberger, Gregory T. Robertson, Nicholas D. Walter	12
7	Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials 2021 ·American Journal of Respiratory and Critical Care Medicine ·Marjorie Z. Imperial, Patrick Phillips, Payam Nahid, Radojka M. Savić	26
8	Advances in clinical trial design: Weaving tomorrow’s TB treatments 2020 ·PLoS Medicine ·Christian Lienhardt, Andrew Nunn, Richard E. Chaisson, Andrew Vernon, Matteo Zignol, Payam Nahid, Éric Delaporte, Tereza Kasaeva	14
9	Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening 2019 ·Diagnostics ·Narges Alipanah, Priya B. Shete, (unknown), Nguyen Viet Nhung, (unknown), Thuong Pham, Hung Van Nguyen, (unknown), (unknown), (unknown), Ha Phan, Patrick Phillips, Adithya Cattamanchi, Payam Nahid	2
10	Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape 2019 ·PLoS Medicine ·Patrick Phillips, Carole D. Mitnick, James D. Neaton, Payam Nahid, Christian Lienhardt, Andrew Nunn	15
11	Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance 2019 ·PLoS Medicine ·Christian Lienhardt, Andrew Vernon, Marco Cavaleri, (unknown), Payam Nahid	11
12	Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model 2017 ·PLoS Medicine ·Emily A. Kendall, Sourya Shrestha, Ted Cohen, Eric L. Nuermberger, Kelly E. Dooley, Licé González-Angulo, Gavin Churchyard, Payam Nahid, Michael Rich, (unknown), (unknown), Christian Lienhardt, David W. Dowdy	19
13	Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays 2016 ·BMC Public Health ·(unknown), (unknown), (unknown), Adithya Cattamanchi, John Metcalfe, Denise M. Connor, Cecily Miller, Jennifer Grinsdale, Julie Higashi, Payam Nahid	11
14	Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial 2014 ·American Journal of Respiratory and Critical Care Medicine ·Susan E. Dorman, Radojka M. Savić, Stefan Goldberg, Jason E. Stout, Neil W. Schluger, Grace Muzanyi, John L. Johnson, Payam Nahid, Emily J. Hecker, Charles M. Heilig, Lorna Bozeman, (unknown), Ruth N. Moro, William R. Mac Kenzie, Kelly E. Dooley, Eric Nuermberger, Andrew Vernon, Marc Weiner	76
15	Update in Tuberculosis and Nontuberculous Mycobacterial Disease 2012 2013 ·American Journal of Respiratory and Critical Care Medicine ·Dick Menzies, Payam Nahid	26
16	Update in Tuberculosis and Nontuberculous Mycobacterial Disease 2011 2012 ·American Journal of Respiratory and Critical Care Medicine ·Payam Nahid, Dick Menzies	13
17	Tuberculosis Biomarker and Surrogate Endpoint Research Roadmap 2011 ·American Journal of Respiratory and Critical Care Medicine ·Payam Nahid, Jussi Saukkonen, William R. Mac Kenzie, John L. Johnson, Patrick Phillips, Janet Andersen, Erin Bliven-Sizemore, John T. Belisle, W. Henry Boom, Annie Luetkemeyer, Thomas Campbell, Kathleen D. Eisenach, Richard Hafner, Jeffrey L. Lennox, Mamodikoe Makhene, Susan Swindells, Margarita E. Villarino, Marc Weiner, Constance A. Benson, William J. Burman	41
18	Factors associated with mortality in patients with drug-susceptible pulmonary tuberculosis 2011 ·BMC Infectious Diseases ·Payam Nahid, Leah G. Jarlsberg, (unknown), Bouke C. de Jong, Alon Unger, L. Masae Kawamura, Dennis Osmond, Philip C. Hopewell, Charles L. Daley	245
19	Evaluation of Quantitative IFN-γ Response for Risk Stratification of Active Tuberculosis Suspects 2009 ·American Journal of Respiratory and Critical Care Medicine ·John Metcalfe, Adithya Cattamanchi, Eric Vittinghoff, Christine Ho, Jennifer Grinsdale, Philip C. Hopewell, L. Masae Kawamura, Payam Nahid	30
20	Treatment Outcomes of Patients with HIV and Tuberculosis 2007 ·American Journal of Respiratory and Critical Care Medicine ·Payam Nahid, Leah C. Gonzalez, (unknown), Bouke C. de Jong, Alon Unger, L. Masae Kawamura, Dennis Osmond, Philip C. Hopewell, Charles L. Daley	99

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact